Rise in Parental Refusal of Newborn Vitamin K Injections Raises Health Concerns

A systematic review presented at the American Academy of Neurology's 78th Annual Meeting highlights a growing trend of parents refusing vitamin K injections for their newborns, a practice that may increase the risk of life-threatening brain bleeds. Vitamin K is essential for blood clotting, and newborns naturally have low levels of this vitamin. Administering a vitamin K shot shortly after birth can prevent vitamin K deficiency bleeding (VKDB), a condition that can lead to severe complications, including intracranial hemorrhage.

The review analyzed 25 studies spanning two decades and found that while overall refusal rates remain below 1%, certain regions have experienced notable increases. In Minnesota, refusal rates rose from 0.9% in 2015 to 1.6% in 2019. In California, Connecticut, and Iowa, rates ranged from 0.2% to 1.3% between 2018 and 2019, with over half of hospital staff perceiving an uptick in refusals. Internationally, refusal rates varied from 1% to 3% in countries like Canada, New Zealand, and Scotland, reaching over 30% in some birthing centers.

Dr. Kate Semidey of Florida International University, the study's author, emphasized the safety and efficacy of vitamin K administration at birth. She noted that infants who do not receive the injection are 81 times more likely to develop VKDB. The review also found that parents who declined the vitamin K shot were more likely to refuse other recommended health interventions, such as vaccinations and eye prophylaxis.

The findings underscore the need for healthcare professionals to provide comprehensive prenatal counseling to ensure parents understand the critical role of vitamin K in preventing severe bleeding disorders in newborns.